D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 57 Citations 10,267 246 World Ranking 2648 National Ranking 1257

Overview

What is she best known for?

The fields of study she is best known for:

  • Immune system
  • Cancer
  • Virus

The scientist’s investigation covers issues in Immunology, Immunotherapy, Antigen, Virology and Adoptive cell transfer. Her work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Hematopoietic stem cell transplantation, Transplantation. Her research in Cytotoxic T cell intersects with topics in T lymphocyte, CD8 and Cell therapy.

As a member of one scientific family, Ann M. Leen mostly works in the field of Immunotherapy, focusing on Genetic enhancement and, on occasion, Virotherapy, Immune tolerance, Oncolytic virus and ELISPOT. She combines subjects such as Epitope and Cellular immunity with her study of Virology. Her Adoptive cell transfer research includes elements of Cytomegalovirus and Graft-versus-host disease.

Her most cited work include:

  • Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. (462 citations)
  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation (350 citations)
  • Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. (259 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of investigation include Immunology, Antigen, Cytotoxic T cell, T cell and Virology. Immunology is frequently linked to Hematopoietic stem cell transplantation in her study. Ann M. Leen has included themes like Adoptive cell transfer and Cancer research in her Antigen study.

Her T cell research is multidisciplinary, relying on both Molecular biology and Oncology. Her Virology study combines topics from a wide range of disciplines, such as Cellular immunity and Virus-specific Cytotoxic T-lymphocytes. Her Immunotherapy research incorporates elements of Viral vector and Lymphoma.

She most often published in these fields:

  • Immunology (74.44%)
  • Antigen (48.52%)
  • Cytotoxic T cell (42.96%)

What were the highlights of her more recent work (between 2017-2021)?

  • Antigen (48.52%)
  • T cell (40.37%)
  • Cancer research (21.11%)

In recent papers she was focusing on the following fields of study:

Ann M. Leen mostly deals with Antigen, T cell, Cancer research, Immunology and Adoptive cell transfer. The concepts of her Antigen study are interwoven with issues in Cytotoxic T cell, PRAME, Cytokine and Survivin. Her Cancer research study integrates concerns from other disciplines, such as Car t cells, Human leukocyte antigen and Immunotherapy.

Her research integrates issues of Allogeneic hematopoietic stem cell transplant and Peripheral blood mononuclear cell in her study of Immunology. Her studies examine the connections between Adoptive cell transfer and genetics, as well as such issues in Chimeric antigen receptor, with regards to Interleukin 4, Prostate Stem Cell Antigen and Graft-versus-host disease. The various areas that Ann M. Leen examines in her CD8 study include Epitope and Virology.

Between 2017 and 2021, her most popular works were:

  • Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment (48 citations)
  • CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation (39 citations)
  • Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE) (27 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Immune system
  • Virus

Ann M. Leen mainly investigates Antigen, Cancer research, Immunotherapy, Cytotoxic T cell and Stem cell. Her study explores the link between Cancer research and topics such as Adoptive cell transfer that cross with problems in Interleukin 4 and Cytokine. Her Immunotherapy research includes themes of Epstein–Barr virus, Human leukocyte antigen, Epitope, Epitope mapping and Major histocompatibility complex.

Many of her studies involve connections with topics such as Immunology and Cytotoxic T cell. Her work deals with themes such as Hematopoietic stem cell and Pneumonia, which intersect with Immunology. The various areas that Ann M. Leen examines in her Hematopoietic stem cell transplantation study include Virus, Immune system, Myeloid leukemia and Transplant Conditioning.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Ann M. Leen;G. Doug Myers;Uluhan Sili;M. Helen Huls.
Nature Medicine (2006)

605 Citations

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall.
Blood (2013)

500 Citations

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Ann M. Leen;Anne Christin;Gary D. Myers;Hao Liu.
Blood (2009)

423 Citations

Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

Anastasia Papadopoulou;Ulrike Gerdemann;Usha L. Katari;Ifigenia Tzannou.
Science Translational Medicine (2014)

408 Citations

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Ifigeneia Tzannou;Anastasia Papadopoulou;Swati Naik;Kathryn Leung.
Journal of Clinical Oncology (2017)

351 Citations

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

Catherine M. Bollard;Stephen Gottschalk;Ann M. Leen;Heidi Weiss.
Blood (2007)

329 Citations

Functionally active virus-specific T-cells that target CMV, adenovirus and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

Patrick J. Hanley;Conrad Russell Young Cruz;Barbara Savoldo;Ann M. Leen.
Blood (2009)

328 Citations

Improving T cell therapy for cancer.

Ann M. Leen;Cliona M. Rooney;Aaron E. Foster.
Annual Review of Immunology (2007)

304 Citations

Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses

Ann Leen;Pauline Meij;Irina Redchenko;Jaap Middeldorp.
Journal of Virology (2001)

270 Citations

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.

Somala Mohammed;Sujita Sukumaran;Pradip Bajgain;Pradip Bajgain;Norihiro Watanabe.
Molecular Therapy (2017)

242 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ann M. Leen

Catherine M. Bollard

Catherine M. Bollard

George Washington University

Publications: 144

Cliona M. Rooney

Cliona M. Rooney

Baylor College of Medicine

Publications: 112

Helen E. Heslop

Helen E. Heslop

Baylor College of Medicine

Publications: 108

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 103

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 72

Barbara Savoldo

Barbara Savoldo

University of North Carolina at Chapel Hill

Publications: 52

Stephen Gottschalk

Stephen Gottschalk

St. Jude Children's Research Hospital

Publications: 50

Elizabeth J. Shpall

Elizabeth J. Shpall

The University of Texas MD Anderson Cancer Center

Publications: 44

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 39

Hao Liu

Hao Liu

Indiana University

Publications: 36

Adrian P. Gee

Adrian P. Gee

Baylor College of Medicine

Publications: 36

Rajiv Khanna

Rajiv Khanna

QIMR Berghofer Medical Research Institute

Publications: 35

Michael Boeckh

Michael Boeckh

Fred Hutchinson Cancer Research Center

Publications: 34

Laurence J.N. Cooper

Laurence J.N. Cooper

The University of Texas MD Anderson Cancer Center

Publications: 32

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 32

Akseli Hemminki

Akseli Hemminki

University of Helsinki

Publications: 31

Trending Scientists

Paul H. Schultz

Paul H. Schultz

University of Notre Dame

Goangseup Zi

Goangseup Zi

Korea University

Yi Xi

Yi Xi

Chongqing University

Toke T. Høye

Toke T. Høye

Aarhus University

Ivica Letunic

Ivica Letunic

European Bioinformatics Institute

Beat Frey

Beat Frey

Swiss Federal Institute for Forest, Snow and Landscape Research

Sudha Agarwal

Sudha Agarwal

The Ohio State University

John S. Peel

John S. Peel

Uppsala University

Yuansong Wei

Yuansong Wei

Chinese Academy of Sciences

Dale W. Griffin

Dale W. Griffin

United States Geological Survey

Hans Op de Beeck

Hans Op de Beeck

Allen Institute for Brain Science

Richard E. Zigmond

Richard E. Zigmond

Case Western Reserve University

Ken Ohta

Ken Ohta

Teikyo University

Juan J. Nogueras

Juan J. Nogueras

Cleveland Clinic

Giorgio Guazzoni

Giorgio Guazzoni

Humanitas University

Anne Kennedy

Anne Kennedy

University of Southampton

Something went wrong. Please try again later.